FDAnews
www.fdanews.com/articles/191796-neumodx-launches-hbv-and-hcv-assays-in-europe

NeuMoDx Launches HBV and HCV Assays in Europe

June 26, 2019

NeuMoDx Molecular has announced the launch of its CE marked Hepatitis B and C virus diagnostic tests.

The assays handle the entire diagnostic process from extraction to detection, providing the first result in approximately one hour.

The devices’ reagents do not require refrigeration. They have an on-board stability of up to 60 days and a shelf life of over one year.

View today's stories